A Study to Evaluate the Effectiveness of Perampanel as Only Add-on Treatment in Participants With Primary or Secondarily Generalized Tonic-clonic Seizures

CompletedOBSERVATIONAL
Enrollment

187

Participants

Timeline

Start Date

January 21, 2020

Primary Completion Date

March 31, 2023

Study Completion Date

March 31, 2023

Conditions
Seizures
Interventions
DRUG

Perampanel

Perampanel tablets.

DRUG

Perampanel

Perampanel oral suspension.

Trial Locations (34)

Unknown

Eisai Trial Site #51, Aalen

Eisai Trial Site #12, Berlin

Eisai Trial Site #43, Berlin

Eisai Trial Site #15, Bernau

Eisai Trial Site #8, Bielefeld

Eisai Trial Site #53, Bochum

Eisai Trial Site #38, Bonn

Eisai Trial Site #9, Bonn

Eisai Trial Site #25, Damp

Eisai Trial Site #48, Dortmund

Eisai Trial Site #27, Dresden

Eisai Trial Site #50, Dresden

Eisai Trial Site #7, Erlangen

Eisai Trial Site #44, Friedrichshafen

Eisai Trial Site #4, Greifswald

Eisai Trial Site #21, Hamburg

Eisai Trial Site #47, Hamburg

Eisai Trial Site #14, Jena

Eisai Trial Site #18, Kiel

Eisai Trial Site #54, Kiel

Eisai Trial Site #1, Kork

Eisai Trial Site #24, Leipzig

Eisai Trial Site #28, Lübeck

Eisai Trial Site #26, Magdeburg

Eisai Trial Site #13, Mainz

Eisai Trial Site #36, Mittweida

Eisai Trial Site #42, Nierstein

Eisai Trial Site #2, Radeberg

Eisai Trial Site #16, Ravensburg

Eisai Trial Site #23, Regensburg

Eisai Trial Site #46, Remscheid

Eisai Trial Site #3, Tübingen

Eisai Trial Site #37, Ulm

Eisai Trial Site #40, Weil der Stadt

All Listed Sponsors
lead

Eisai GmbH

INDUSTRY

NCT04202159 - A Study to Evaluate the Effectiveness of Perampanel as Only Add-on Treatment in Participants With Primary or Secondarily Generalized Tonic-clonic Seizures | Biotech Hunter | Biotech Hunter